ARTIVION INC (NYSE: AORT)

ARTIVION INC

NYSE: AORT (Artivion, Inc.)

Last update: 18 Feb, 5:16PM

37.52

1.02 (2.79%)

Add to watchlist

Previous Close	36.50
Open	36.73
Volume	287,106
Avg. Volume (3M)	357,445
Market Cap	1,795,069,440

Price / Earnings (TTM)	178.67
Price / Earnings (Forward)	62.50
Price / Sales	4.12
Price / Book	4.12

52 Weeks Range	21.97 (-41%) — 48.25 (28%)
Earnings Date	4 May 2026

Market Trend

		Short Term	Medium Term
Industry	Medical Devices (US)	Mixed	Bearish
	Medical Devices (Global)	Mixed	Bearish
Stock	Artivion, Inc.	Bullish	Bullish

AIStockmoo Score

1.4

Analyst Consensus	3.0
Insider Activity	0.0
Price Volatility	2.0
Technical Moving Averages	2.5
Technical Oscillators	-0.5
Average	1.40

Similar Stocks

Stock	Market Cap	DY	P/E (TTM)	P/B
AORT	2 B	-	178.67	4.12
PEN	13 B	-	74.75	9.88
GMED	13 B	-	31.14	2.85
GKOS	7 B	-	-	10.66
ITGR	3 B	-	35.36	1.71
INSP	3 B	-	64.90	2.36

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company’s products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
Sector	Healthcare
Industry	Medical Devices
Investment Style	Small Growth
% Held by Insiders	5.01%
% Held by Institutions	98.14%

Ownership

Name	Date	Shares Held
Juniper Investment Company, Llc	30 Sep 2025	1,333,692

52 Weeks Range	21.97 (-41%) — 48.25 (28%)
Price Target Range	48.00 (27%) — 58.00 (54%)
High	58.00 (Needham, 54.58%)	Buy
Median	53.00 (41.26%)
Low	48.00 (Canaccord Genuity, 27.93%)	Buy
Average	53.00 (41.26%)
Total	2 Buy
Avg. Price @ Call	38.92

Firm	Date	Target Price	Call	Price @ Call
Canaccord Genuity	13 Feb 2026	48.00 (27.93%)	Buy	36.60
Needham	02 Feb 2026	58.00 (54.58%)	Buy	41.23

Name	Avg. Buy ($)	Avg. Sell ($)	Net Quantity	Net Value ($)
BERRY LANCE A	35.35	36.37	28,016	980,204
DAVIS JOHN E	35.35	36.37	14,590	508,060
HOLLOWAY JEAN F	35.35	36.37	15,338	535,917
HORTON AMY	35.35	36.37	3,097	105,948
MACKIN JAMES P	35.35	36.37	62,132	2,153,604
STANTON MARSHALL S.	-	36.37	-3,682	-135,102
Aggregate Net Quantity				119,491
Aggregate Net Value ($)				4,148,631
Aggregate Avg. Buy ($)				35.35
Aggregate Avg. Sell ($)				36.37
Insider Range ($)				35.35 (-5%) — 37.39 (-0%)

Name	Holder	Date	Type	Quantity	Price	Value ($)
DAVIS JOHN E	Officer	24 Feb 2026	Sell (-)	2,075	35.35	73,351
DAVIS JOHN E	Officer	24 Feb 2026	Acquired (+)	20,438	35.35	722,483
BERRY LANCE A	Officer	24 Feb 2026	Sell (-)	4,485	35.35	158,545
BERRY LANCE A	Officer	24 Feb 2026	Acquired (+)	37,482	35.35	1,324,989
MACKIN JAMES P	Officer	24 Feb 2026	Sell (-)	13,936	35.35	492,638
MACKIN JAMES P	Officer	24 Feb 2026	Acquired (+)	97,030	35.35	3,430,011
HOLLOWAY JEAN F	Officer	24 Feb 2026	Sell (-)	1,668	35.35	58,964
HOLLOWAY JEAN F	Officer	24 Feb 2026	Acquired (+)	20,085	35.35	710,005
STANTON MARSHALL S.	Officer	24 Feb 2026	Sell (-)	1,259	35.35	44,506
HORTON AMY	Officer	24 Feb 2026	Sell (-)	830	35.35	29,341
HORTON AMY	Officer	24 Feb 2026	Acquired (+)	5,658	35.35	200,010
DAVIS JOHN E	Officer	23 Feb 2026	Sell (-)	3,773	37.39	141,072
BERRY LANCE A	Officer	23 Feb 2026	Sell (-)	4,981	37.39	186,240
MACKIN JAMES P	Officer	23 Feb 2026	Sell (-)	20,962	37.39	783,769
HOLLOWAY JEAN F	Officer	23 Feb 2026	Sell (-)	3,079	37.39	115,124
STANTON MARSHALL S.	Officer	23 Feb 2026	Sell (-)	2,423	37.39	90,596
HORTON AMY	Officer	23 Feb 2026	Sell (-)	1,731	37.39	64,722
Show more

Date	Type	Details
02 Feb 2026	Announcement	Artivion Announces Presentation of Positive New Clinical Data from NEXUS TRIOMPHE and AMDS PERSEVERE Trials at the 62nd Society of Thoracic Surgery Annual Meeting
29 Jan 2026	Announcement	Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter 2025 Financial Results

5Y Average Dividend Yield

0.00%

Ex Date	Announcement Date	Payment Date	Details
09 Dec 2015	22 Oct 2015	18 Dec 2015	0.03 Cash
09 Sep 2015	22 Jul 2015	18 Sep 2015	0.03 Cash
10 Jun 2015	21 May 2015	19 Jun 2015	0.03 Cash
11 Mar 2015	13 Feb 2015	20 Mar 2015	0.03 Cash
10 Dec 2014	23 Oct 2014	19 Dec 2014	0.03 Cash
10 Sep 2014	30 Jul 2014	19 Sep 2014	0.03 Cash
11 Jun 2014	22 May 2014	20 Jun 2014	0.03 Cash
12 Mar 2014	19 Feb 2014	21 Mar 2014	0.0275 Cash
11 Dec 2013	21 Nov 2013	20 Dec 2013	0.0275 Cash
11 Sep 2013	21 Aug 2013	20 Sep 2013	0.0275 Cash
12 Jun 2013	28 May 2013	21 Jun 2013	0.0275 Cash
12 Mar 2013	13 Feb 2013	21 Mar 2013	0.025 Cash
12 Dec 2012	19 Nov 2012	21 Dec 2012	0.025 Cash
12 Sep 2012	21 Aug 2012	21 Sep 2012	0.025 Cash
Show more

Annual Dividend Yield

Year	Annual Dividend ($)	Frequency/Year	Yield %
2015	0.120	4	1.11
2014	0.118	4	1.04
2013	0.108	4	0.97
2012	0.050	2	0.80

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Realized Profit	-
Unrealized Profit	-
Dividend Received 2026	-
Total Profit	-
Avg. Return	-
Quantity (Buy)	-
Avg. Price (Buy)	-
Quantity (Sold)	-
Avg. Price (Sold)	-

No stocks matching your criteria

Profit Margin	-5.49%
Operating Margin (TTM)	-0.69%
Diluted EPS (TTM)	-0.510
Quarterly Revenue Growth (YOY)	1.60%

Total Debt/Equity (MRQ)	123.15%
Current Ratio (MRQ)	5.53
Operating Cash Flow (TTM)	10.78 M
Levered Free Cash Flow (TTM)	-14.03 M

Return on Assets (TTM)	1.54%
Return on Equity (TTM)	-7.26%

Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)